Addison Capital CO Seagen Inc. Transaction History

Addison Capital CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 18, 2023	SELL	$187.64 - $206.25 $27,207 - $29,906	-145 Reduced 1.49%	9,604 $1.85 Million
Q2 2022 Jul 11, 2022	SELL	$108.81 - $179.33 $32,643 - $53,799	-300 Reduced 2.99%	9,749 $1.73 Million
Q1 2022 Apr 11, 2022	BUY	$119.61 - $157.85 $203,337 - $268,345	1,700 Added 20.36%	10,049 $1.45 Million
Q3 2021 Oct 12, 2021	BUY	$142.45 - $169.82 $4,985 - $5,943	35 Added 0.42%	8,349 $1.42 Million
Q2 2021 Jul 16, 2021	BUY	$135.08 - $161.1 $77,671 - $92,632	575 Added 7.43%	8,314 $1.31 Million

Q1 2021 Apr 12, 2021	SELL	$137.51 - $190.8 $22,139 - $30,718	-161 Reduced 2.04%	7,739 $1.08 Million
Q4 2020 Jan 12, 2021	BUY	$164.63 - $211.93 $1.3 Million - $1.67 Million	7,900 New	7,900 $1.38 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

Stay updated on Addison Capital CO with notifications on news.